Argent Biopharma (LSE:RGT) Change In Inventory : £0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Argent Biopharma Change In Inventory?

Argent Biopharma's change in inventory for the quarter that ended in Dec. 2024 was £0.00 Mil. It means Argent Biopharma's inventory stayed the same from Jun. 2024 to Dec. 2024 .

Argent Biopharma's change in inventory for the fiscal year that ended in Jun. 2024 was £0.00 Mil. It means Argent Biopharma's inventory stayed the same from Jun. 2023 to Jun. 2024 .

Argent Biopharma's Total Inventories for the quarter that ended in Dec. 2024 was £0.17 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Argent Biopharma's Days Inventory for the quarter that ended in Dec. 2024 was 28,378.75.

Inventory Turnover measures how fast the company turns over its inventory within a year. Argent Biopharma's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.01.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Argent Biopharma's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 1.76.

Argent Biopharma Change In Inventory Historical Data

The historical data trend for Argent Biopharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argent Biopharma Change In Inventory Chart

Argent Biopharma Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Change In Inventory

Get a 7-Day Free Trial

Argent Biopharma Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Argent Biopharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

Argent Biopharma (LSE:RGT) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Argent Biopharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.311	/	0.002	*	365 / 2
	=	28,378.75

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Argent Biopharma's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.002	/	0.311
	=	0.01

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Argent Biopharma's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.311	/	0.177
	=	1.76

Argent Biopharma Change In Inventory Related Terms

Thank you for viewing the detailed overview of Argent Biopharma's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Argent Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Argent Biopharma Ltd (LSE:RGT) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

RGTLF:USA H5O0:Germany RGT:Australia

Address

295 Rokeby Road, Suite 1, Subiaco, WA, AUS, 6008

Website

https://www.argentbiopharma.com

Argent Biopharma Ltd is a drug discovery company that addresses unmet medical needs. The company focuses on multidisciplinary methods with nanotechnology, developing multi-target therapies for comprehensive disease management, especially in the central nervous system and immunology treatments. The products of the company include CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury, and ARDS, and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development, and others.